Auckland Allergy Clinic HomeWhat's NewThe ClinicDoctors ProfileAllergy GuideTerminologyAppointmentsQuestionnaireLinksFeedbackContact Us
WHAT'S NEW - OCTOBER 2003

Welcome to the Auckland Allergy Clinic web site. This section will bring you the latest breaking news in Allergy & Clinical Immunology and also additions we have made to the Clinic in the last month.

The Allergy News information provided on this web site is reviewed and approved by the Allergists at the Auckland Allergy Clinic. The information is sourced from International Medical Journals and Newspapers. These articles are chosen either because they are thought to be particularly good studies, very interesting Allergy News or relevant to New Zealand. The articles may not necessarily be the views of the editor. Where relevant the editor will add his/her comments at the bottom of the review.

These updates are provided for educational, communication and information purposes only.

You can have these updates emailed to you in the form of a monthly newsletter, by subscribing to our What's New Newsletter.



Previous Newsletters:

August/September 2003
June/July 2003
April/May 2003

March 2003
February 2003
January 2003
November/December 2002
October 2002
September 2002

July/August 2002
June 2002
May 2002
April 2002
March 2002
January/February 2002

December 2001
November 2001
October 2001
September 2001
August 2001
July 2001

This Month's Feature Review:

Idiopathic Anaphylaxis: An Update

Vincent St Aubyn Crump

Idiopathic Anaphylaxis (IA) is a well-described syndrome of anaphylaxis without any recognised external trigger. These patients present with the same symptoms as patients with other types of anaphylactic reaction. The attacks occur with variable frequency. Fatalities have been reported in patients who have been diagnosed with idiopathic anaphylaxis.

Bacal et al first reported IA in 1978 [1], when they published data on 11 patients whose episode of anaphylaxis could not be explained. The series has been expanded to include over 335 patients. Atopy was noted in 48% of the patients (the same percentage implicated in the Spanish series of 81 patients).

The disease exists in all age groups and proves expensive if not diagnosed and treated early. It is reported to be more common in women, with 65% of 335 idiopathic anaphylaxis patients being women in the largest published series in the literature.

Read the Full Article

New and Interesting Allergy Studies:

Maternal dietary antigen avoidance during pregnancy and/or lactation for prevention or treating atopic disease in the child (Cochrane Review)

Maternal dietary antigen avoidance during pregnancy and/or lactation for prevention or treating atopic disease in the child (Cochrane Review)

Kramer MS, Kukuma R

Background: Some breast-fed infants with atopic eczema benefit from elimination of cows milk, egg, or other antigens from their mothers diet. Maternal antigens are also known to cross the placenta.

Objectives: To assess the effects of prescribing an antigen avoidance diet during pregnancy and/or lactation on maternal & infant nutrition and on the prevention or treatment of atopic diseases in the child.

Search Strategy: The Cochrane Pregnancy & childbirth Group trials register (October 2002) was searched and researchers in the field contacted.

Selection criteria: All randomised or quasi-randomised comparisons of maternal dietary antigen avoidance prescribed to pregnant or lactating women. Trials with multimodal interventions that included manipulation of the infants diet other than breast milk or of nondietary aspects of the infants diet were excluded.

Data collection & analysis: Data was extracted from published reports, supplemented by additional information received from the researchers that were contacted.

Results: The evidence from 4 trials involving approximately 451 participants did not suggest a protective effect of maternal dietary antigen avoidance during pregnancy on the incidence of atopic eczema during the first 12 to 18 months of life.

The restricted diet during pregnancy was associated with a slightly but statistically significant lower mean gestational weight gain, nonsignificantly higher risk of preterm birth, and a nonsignificant reduction in mean birthweight.

The evidence from 3 trails involving approximately 210 participants suggests a protective effect of maternal antigen avoidance in lactation on the incidence and severity of atopic eczema during the first 12 to 18 months.

Reviewers conclusions: "Prescription of antigen avoidance diet to a high-risk woman during pregnancy is unlikely to substantially reduce her childs risk of atopic diseases, and such a diet may adversely affect maternal and/or fetal nutrition.

Prescriptopn of an allergen avoidance diet to a high-risk mother during lactation may reduce her childs risk of atopic eczema, but better trials are needed.

Dietary allergen avoidance by lactating mothers of infants with atopic eczema may reduce the severity of the eczema, but larger trials are needed."